James Matera, DO, on the Renoprotective Effects of SGLT2 Inhibitors in DKD
Dr Matera reviews recent evidence that has demonstrated the potential renal protection offered by sodium glucose co-transporter 2 inhibitors against diabetic kidney disease. For more, visit www.consultant360.com/endocrinology.